17 June 2015 | Influencers | By BioSpectrum Bureau
Top 20 APAC Country Analysis: China
Singapore:
• In a bid to deepen healthcare reforms and improve health infrastructure, China increased in healthcare subsidies by 19 percent
• National Development and Reforms Commission removed the price controls on most pharmaceuticals to reduce government intervention and enhance opportunities
• Plans to use competitive bidding for large-scale purchases of certain drugs as a way to guide market pricing and reduce costs of essential drugs
• Chinese government cracked down on rampant bribery by pharmaceutical companies that inflated drug prices